Tapinarof

Unassigned

New Medicines

Plaque psoriasis in adults

Information

New molecular entity
Dermavant Sciences GmbH
Dermavant Sciences GmbH

Development and Regulatory status

None
None
Phase III Clinical Trials

Category

Aryl hydrocarbon receptor agonist
Psoriasis affects about 1.3 to 2.2% of people in the UK, with 90% of cases being plaque psoriasis. Highest prevalence in white people [1].
Plaque psoriasis in adults
Topical